Substances · Arylcyclohexylamines
DMXE (Deoxymethoxetamine)
- Preferred name
- DMXE (Deoxymethoxetamine)
- IUPAC name
- 2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one
- Parent CAS number (reference)
- 2666932-45-0
- Molecular formula
- C15H21NO
- Molecular weight
- 231.33 g/mol
- InChIKey
- WIMLPRYZJQNQLE-UHFFFAOYSA-N
- PubChem
- CID 157010705
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
Deoxymethoxetamine 3D-MXE DMXE 3-Me-2'-oxo-PCE
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
DMXE (Deoxymethoxetamine)
Receptor Telemetry & Mechanism of Action
Deoxymethoxetamine replacing MXE's 3-methoxy group with 3-methyl, preserving warm NMDA dissociation and monoaminergic warmth.
Biotransformation & Active Metabolites
Hepatic N-deethylation and ring hydroxylation.
Temporal Pharmacokinetics
3-Methyl-2'-oxo-PCE Dissociative (NMDA Antagonist) — Closest modern structural sibling to MXE, requiring ~20–25% higher milligram amounts (common 30–55 mg) with slightly shorter 3.5–5 h duration.
- Onset 20–45 min
- Peak Window 1–2.5 h
- Total Window 3.5–5 h
- Residual / Half-Life 3–6 h residual
Closest modern structural sibling to MXE, requiring ~20–25% higher milligram amounts (common 30–55 mg) with slightly shorter 3.5–5 h duration.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
8–15 mg
Subtle threshold receptor activity (3-Methyl-2'-oxo-PCE Dissociative (NMDA Antagonist)).
Minimal baseline autonomic shift.
15–30 mg
Mild, clear-headed expression of primary class profile.
Light somatic modulation.
30–55 mg
Full characteristic neurochemical and perceptual profile documented in literature.
Moderate somatic relaxation, ataxia, or autonomic tone depending on class.
55–80 mg
Pronounced intensity, cognitive/motor impairment, or deep immersion.
Marked somatic load and heightened adverse-event sensitivity.
85+ mg
Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.
High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Severe ataxia, unconsciousness, respiratory depression, and fatal vomiting aspiration.
SERT inhibition combined with monoamine releasers or MAOIs precipitates potentially fatal serotonin syndrome and hyperthermia.
Elevated Hazard — Avoid
Compounds hypertension, tachycardia, manic disorientation, and psychotic episodes.
Caution / Receptor Attenuation
Dramatically intensifies dissociation, confusion, and sensory immersion.
Structural Isomer & Sibling Comparison
Closest modern structural sibling to MXE, requiring ~20–25% higher milligram amounts (common 30–55 mg) with slightly shorter 3.5–5 h duration.
Physicochemical Stability & Storage
Form: White to off-white crystalline powder or fine crystals. · Soluble in water, ethanol, and saline.
Chemically stable when kept dry, sealed, and protected from light at room temperature.
Cross-Tolerance & Dependence Profile
Slowly decaying NMDA cross-tolerance shared across all arylcyclohexylamines (halves in ~3–7 days, full baseline 2+ weeks). Chronic frequent exposure carries documented urological/bladder epithelial toxicity.
Chemical Architecture & Structural Profile
DMXE (Deoxymethoxetamine) (2-(ethylamino)-2-(3-methylphenyl)cyclohexan-1-one) is a reference compound belonging to the Arylcyclohexylamines class, characterized by the molecular formula C15H21NO and a molar mass of 231.33 g/mol. The parent molecule is indexed under CAS registry number 2666932-45-0 and in the NCBI PubChem database as CID 157010705 (Standard InChIKey: WIMLPRYZJQNQLE-UHFFFAOYSA-N). This molecule shares its empirical formula (C15H21NO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (2666932-45-0), and spectroscopic profile.
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), DMXE (Deoxymethoxetamine) is indexed within the Arylcyclohexylamines structural group. Arylcyclohexylamine derivative; toxicological literature highlights severe hazard interactions when combined with central nervous system depressants (alcohol, GHB/GBL, opioids, benzodiazepines). Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- legislation.gov.uk — Misuse of Drugs Act 1971 & Psychoactive Substances Act 2016 — The National Archives (UK) (2026-11-12)